Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Peselow

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Psychiatry|July 1, 1994
Trazodone for antidepressant-associated insomniaA A Nierenberg, L A Adler, E Peselow, et al.
Journal of Neural Transmission|January 1, 1988
Preliminary studies of clonidine in psychotic patientsB Angrist, M Smith, L Adler, et al.
Acta Psychiatrica Scandinavica|May 1, 1986
General behavior inventory: measurement of subclinical changes during depression and lithium prophylaxisP J Goodnick, R R Fieve, E Peselow, et al.
Neuropsychobiology|January 1, 1987
Platelet 3H-imipramine binding and familial transmission of affective disordersM Baron, A Barkai, R Gruen, et al.
The American Journal of Psychiatry|June 1, 1986
Platelet [3H]imipramine binding in affective disorders: trait versus state characteristicsM Baron, A Barkai, R Gruen, et al.
Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.
The American Journal of Psychiatry|September 1, 1993
Vitamin E treatment of tardive dyskinesiaL A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry|June 17, 1998
Long-term treatment effects of vitamin E for tardive dyskinesiaL A Adler, R Edson, P Lavori, et al.
Psychopharmacology Bulletin|January 1, 1984
Cholecystokinin octapeptide in dementiaM Serby, B Angrist, J Corwin, et al.
Journal of Communication Disorders|August 1, 1990
Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of testsJ C Borod, J Welkowitz, M Alpert, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Psychiatry|July 1, 1994
Trazodone for antidepressant-associated insomniaA A Nierenberg, L A Adler, E Peselow, et al.
Journal of Neural Transmission|January 1, 1988
Preliminary studies of clonidine in psychotic patientsB Angrist, M Smith, L Adler, et al.
Acta Psychiatrica Scandinavica|May 1, 1986
General behavior inventory: measurement of subclinical changes during depression and lithium prophylaxisP J Goodnick, R R Fieve, E Peselow, et al.
Neuropsychobiology|January 1, 1987
Platelet 3H-imipramine binding and familial transmission of affective disordersM Baron, A Barkai, R Gruen, et al.
The American Journal of Psychiatry|June 1, 1986
Platelet [3H]imipramine binding in affective disorders: trait versus state characteristicsM Baron, A Barkai, R Gruen, et al.
Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.
The American Journal of Psychiatry|September 1, 1993
Vitamin E treatment of tardive dyskinesiaL A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry|June 17, 1998
Long-term treatment effects of vitamin E for tardive dyskinesiaL A Adler, R Edson, P Lavori, et al.
Psychopharmacology Bulletin|January 1, 1984
Cholecystokinin octapeptide in dementiaM Serby, B Angrist, J Corwin, et al.
Journal of Communication Disorders|August 1, 1990
Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of testsJ C Borod, J Welkowitz, M Alpert, et al.
Pageof 4